@article{fdi:010072409,
  title = {{P}harmaceutical capitalism and its logistics : access to hepatitis {C} treatment},
  author = {{Q}uet, {M}athieu},
  editor = {},
  language = {{ENG}},
  abstract = {{N}ew and highly effective treatments against hepatitis {C} have come on the market in recent years. {T}heir high cost has sparked vociferous debate concerning drug price control, the state's responsibility towards infected populations and the power of multinational pharmaceutical companies. {O}ne possible way to understand these debates is to take into account the particular effects of pharmaceutical capitalism upon the circulation of commodities. {R}ecent protests related to access to treatment identify circulation of medicines as an increasing site of capital accumulation and conflicts. {T}his article defines the notion of logistic regimes' and shows how such regimes are contested. {I}t analyzes critical ways of engaging with contemporary pharmaceutical logistics, through variations on medical tourism, critiques of patenting and pricing practices, and organization of alternative supply routes. {I}t further proposes to deepen the notion of diversion as a political concept describing specific forms of opposition to the management practices of logistical capitalism.},
  keywords = {buyers' club ; drugs ; hepatitis ; {I}ndia ; logistics ; sofosbuvir ; {INDE}},
  booktitle = {},
  journal = {{T}heory {C}ulture and {S}ociety},
  volume = {35},
  numero = {2},
  pages = {67--89},
  ISSN = {0263-2764},
  year = {2018},
  DOI = {10.1177/0263276417727058},
  URL = {https://www.documentation.ird.fr/hor/fdi:010072409},
}